Clinical trial
CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
NCT00295425 · University Hospital Muenster, Other · Unknown status
Key facts
| NCT number | NCT00295425 |
|---|---|
| Title | CYA Versus MMF for Treatment of Moderate-Severe Psoriasis. |
| Official title | Open, Multicenter, Randomized Clinical Trial in Patients With Moderate-Severe Psoriasis (PASI > 10) to Compare the Efficacy of Mycophenolate Mofetil Versus Cyclosporine A. |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Cyclosporine A versus mycophenolate mofetil for psoriasis |
| Enrollment | 50 |
| Start date | May 1, 2000 |
| Completion | Oct 1, 2006 |
| First posted | Feb 23, 2006 |
| Last update posted | Oct 5, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: